Marex Group »

Viking Therapeutics shares owned by Marex Group

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Marex Group from 13F filings

Historical chart of Marex Group investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Marex Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Marex Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.0M 39k 26.28
2025-06-30 $983k 37k 26.50

More positions owned by Marex Group

Tesla Motors Call Option (TSLA)
Mastercard Incorporated Cl A (MA)
Booking Holdings (BKNG)
Microsoft Corporation Call Option (MSFT)
Strategy Cl A New (MSTR)
UnitedHealth (UNH)
NVIDIA Corporation Call Option (NVDA)
Eli Lilly & Co. (LLY)
Valkyrie Bitcoin (BRRR)
Apple (AAPL)
Netflix (NFLX)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Meta Platforms Cl A (META)
Broadcom Call Option (AVGO)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)

View all positions for Marex Group

Top funds holding Viking Therapeutics

Vanguard Group
Susquehanna International
FMR
BlackRock
State Street Corporation
Citadel Advisors
Morgan Stanley
Jpmorgan Chase & Co
Ameriprise Financial
Two Sigma Investments
Jane Street
Geode Capital Management
Two Sigma Advisers
UBS Group
Pictet Asset Management Holding SA

View all funds holding Viking Therapeutics